176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.16%
Revenue growth at 75-90% of MU's 10.99%. Bill Ackman would push for innovation or market expansion to catch up.
9.87%
Gross profit growth similar to MU's 9.77%. Walter Schloss would assume both firms track common industry trends.
9.29%
EBIT growth 50-75% of MU's 17.75%. Martin Whitman would suspect suboptimal resource allocation.
9.29%
Operating income growth at 50-75% of MU's 17.75%. Martin Whitman would doubt the firm’s ability to compete efficiently.
3.79%
Net income growth under 50% of MU's 16.04%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.21%
EPS growth under 50% of MU's 18.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.19%
Diluted EPS growth under 50% of MU's 17.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.24%
Slight or no buybacks while MU is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.24%
Slight or no buyback while MU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.24%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-43.36%
Negative OCF growth while MU is at 5.79%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-48.06%
Negative FCF growth while MU is at 23.89%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
547.35%
10Y revenue/share CAGR above 1.5x MU's 253.26%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
205.23%
5Y revenue/share CAGR above 1.5x MU's 54.43%. David Dodd would look for consistent product or market expansions fueling outperformance.
117.67%
3Y revenue/share CAGR 1.25-1.5x MU's 79.36%. Bruce Berkowitz might see better product or regional expansions than the competitor.
503.88%
10Y OCF/share CAGR 1.25-1.5x MU's 396.74%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
185.61%
5Y OCF/share CAGR above 1.5x MU's 58.59%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
204.05%
3Y OCF/share CAGR above 1.5x MU's 40.68%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1243.02%
Net income/share CAGR above 1.5x MU's 828.60% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
291.49%
5Y net income/share CAGR above 1.5x MU's 58.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
95.27%
Below 50% of MU's 210.65%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
481.97%
10Y equity/share CAGR in line with MU's 460.17%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
284.93%
5Y equity/share CAGR 1.25-1.5x MU's 203.10%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
144.83%
3Y equity/share CAGR above 1.5x MU's 38.64%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
41.17%
Dividend/share CAGR of 41.17% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
7.12%
3Y dividend/share CAGR of 7.12% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
10.26%
AR growth well above MU's 15.69%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.63%
Inventory growth well above MU's 4.57%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.13%
Asset growth above 1.5x MU's 2.51%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.27%
BV/share growth above 1.5x MU's 5.04%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-7.68%
We’re deleveraging while MU stands at 0.51%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
12.69%
We increase R&D while MU cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
5.89%
SG&A growth well above MU's 0.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.